Immutep Quote - IMM

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.34

Bid

0.335

Offer

0.345

Volume

1,669,673

0.3325 Day's Range 0.35

0.23 52 Week Range 0.485

Market Cap

298.89M

Previous Close

0.345

Open

0.345

Last Trade

3443

0.345

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,618,409

Shares Outstanding

879,089,453

Dividend Yield

PE Ratio

-7.00

Earnings Per Share (EPS)

-0.05

Revenue

Net Profit

-42.72M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.immutep.com

Headquarters

Sydney, New South Wales, Aus

Founded

Immutep Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMM. The last closing price for Immutep was AUD0.35. Over the last year, Immutep shares have traded in a share price range of AUD 0.23 to AUD 0.485.

Immutep currently has 879,089,453 shares in issue. The market capitalisation of Immutep is AUD303.29 million. Immutep has a price to earnings ratio (PE ratio) of -7.00.

Immutep Has Successful Type C Meeting With FDA

By Chris Wack Immutep Ltd. said Friday it had a successful Type C meeting with the U.S. Food and Drug Administration regarding late-stage clinical development plans for its first-in-class soluble...

Immutep Gets Fast Track Designation for Eftilagimod Alpha Cancer Treatment

By Chris Wack Immutep Ltd. said Tuesday that the U.S. Food and Drug Administration granted fast track designation to eftilagimod alpha IMP321 in combination with pembrolizumab for the treatment of...

Immutep in Collaboration, Supply Agreement With Merck KGaA

By Chris Wack Immutep Limited is in a new collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, for a Phase I/IIa clinical trial in patients with solid tumors. The biotechnology...

Immutep Says Interim Phase II TACTI-002 Data Positive

By Michael Dabaie Immutep Ltd. said interim data was positive from its ongoing Phase II TACTI-002 study. ADRs were down 1% to $3.00 premarket. The data relates to use of the company's lead...

Immtech to be Listed on OTC Market

NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading its common stock on the Pink OTC Markets quotation...

Immtech to Reorganize Research and Development Operations

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its R&D operations. This restructuring will direct...

Immtech Announces Investment in China

NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in Gold Avenue Ltd., a privately-held Hong Kong company...

Immtech Receives Listing Determination Letter

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company received notice from the NYSE Amex LLC (the...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming...

Immtech To Reschedule Quarterly Conference Call

NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM) announced today that the Company will postpone the quarterly update conference call scheduled...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	3.0303030303	0.33	0.35	0.32	1615876	0.32801909	DE
4	-0.02	-5.55555555556	0.36	0.37	0.315	1260147	0.33224289	DE
12	0.05	17.2413793103	0.29	0.385	0.27	2618409	0.32743417	DE
26	0	0	0.34	0.415	0.27	3223330	0.33263857	DE
52	0.005	1.49253731343	0.335	0.485	0.23	3177824	0.35155541	DE
156	-0.03	-8.10810810811	0.37	0.485	0.225	1838503	0.33819797	DE
260	0.025	7.93650793651	0.315	0.725	0.1	2115383	0.36712693	DE

IMM - Frequently Asked Questions (FAQ)

What is the current Immutep share price?

The current share price of Immutep is AUD 0.34

How many Immutep shares are in issue?

Immutep has 879,089,453 shares in issue

What is the market cap of Immutep?

The market capitalisation of Immutep is AUD 303.29M

What is the 1 year trading range for Immutep share price?

Immutep has traded in the range of AUD 0.23 to AUD 0.485 during the past year

What is the PE ratio of Immutep?

The price to earnings ratio of Immutep is -7

What is the reporting currency for Immutep?

Immutep reports financial results in AUD

What is the latest annual profit for Immutep?

The latest annual profit of Immutep is AUD -42.72M

What is the registered address of Immutep?

The registered address for Immutep is LEVEL 12, 95 PITT STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Immutep website address?

The website address for Immutep is www.immutep.com

Which industry sector does Immutep operate in?

Immutep operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CR3ODCore Energy Minerals Ltd	AUD 0.003 (200.00%)	3.57M
NAGONagambie Resources Limited	AUD 0.002 (100.00%)	550k
NRZONeuRizer Ltd	AUD 0.003 (50.00%)	6.13k
EELENRG Elements Ltd	AUD 0.0015 (50.00%)	21.49k
MVPMedical Developments International Limited	AUD 0.645 (48.28%)	1.42M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
BDTBirdDog Technology Ltd	AUD 0.037 (-33.93%)	7.86M
NRZNeuRizer Ltd	AUD 0.002 (-33.33%)	5.92M
MGUOMagnum Mining and Exploration Ltd	AUD 0.002 (-33.33%)	1.14M
ATHAlterity Therapeutics Ltd	AUD 0.0115 (-36.11%)	123.58M
VAUVault Minerals Ltd	AUD 0.385 (5.48%)	49.45M
ATHOAlterity Therapeutics Limited	AUD 0.007 (-41.67%)	46.52M
SYASayona Mining Limited	AUD 0.023 (4.55%)	42.72M
LOTLotus Resources Limited	AUD 0.25 (6.38%)	42.53M